HIM
IDXX icon

Hutchens Investment Management’s Idexx Laboratories IDXX Stock Holding History

Hutchens Investment Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$297K Hold
1,900
– – 0.28% 69
2017
Q3 		$295K Buy
+1,900
New +$300K 0.27% 70

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Hutchens Investment Management's IDXX Position: Q4 2017 in Review

Hutchens Investment Management held its Idexx Laboratories (IDXX) position steady in Q4 2017 at 1,900 shares worth $297K. The position accounts for 0.28% of the portfolio, ranked #69.

Hutchens Investment Management first reported a position in IDXX in Q3 2017 and has held it in 2 quarters since. 613 funds tracked by Wall St. Rank hold IDXX as of Q4 2017.

  • Hutchens Investment Management held 1,900 shares of Idexx Laboratories worth $297K as of Q4 2017.
  • Hutchens Investment Management left its Idexx Laboratories share count unchanged in Q4 2017.
  • Idexx Laboratories made up 0.28% of Hutchens Investment Management's portfolio in Q4 2017, its #69 holding.
  • Hutchens Investment Management first reported a position in Idexx Laboratories in Q3 2017 and has held it in 2 quarters since.
  • 613 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2017.

Based on Hutchens Investment Management's 13F filing for Q4 2017, filed 10 Jan 2018.